Metazachlor: Mode of action analysis for rat liver tumour formation and human relevance

Toxicology - Tập 426 - Trang 152282 - 2019
Christiane Wiemann1, Manuela Goettel2, Audrey Vardy3, Barbara M. Elcombe3, Clifford R. Elcombe3, Lynsey R. Chatham3, Hongbing Wang4, Linhao Li4, Roland Buesen2, Naveed Honarvar2, Silke Treumann2, Heike Marxfeld2, Sibylle Groeters2, Brian G. Lake3,5
1BASF Oesterreich GmbH, Handelskai 94-96, 1200, Vienna, Austria
2BASF SE, 67056 Ludwigshafen, Germany
3Concept Life Sciences (formerly CXR Biosciences Ltd.), 2, James Lindsay Place, Dundee Technopole, Dundee, DD1 5JJ, United Kingdom
4Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
5Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey GU2 7XH, United Kingdom

Tài liệu tham khảo

Anon, 2008, Conclusion regarding the peer review of the pesticide risk assessment of the active substance metazachlor, EFSA Scientific Report, 145, 1 Bahnemann, 1997, Lobule-dependent zonal measurement (LZM) method for the determination of cell proliferation in the liver, Exp. Toxicol. Pathol., 49, 189, 10.1016/S0940-2993(97)80006-1 Boobis, 2006, IPCS framework for analysing the relevance of a cancer mode of action for humans, Crit. Rev. Toxicol., 36, 781, 10.1080/10408440600977677 Burke, 1994, Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver, Biochem. Pharmacol., 48, 923, 10.1016/0006-2952(94)90363-8 Choi, 2017, Mode of action and human relevance of THF-induced mouse liver tumors, Toxicol. Lett., 276, 138, 10.1016/j.toxlet.2017.05.006 Cohen, 2010, Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary, Toxicol. Pathol., 38, 487, 10.1177/0192623310363813 Cohen, 2011, Chemical carcinogenesis, Toxicol. Sci., 120, S76, 10.1093/toxsci/kfq365 Corton, 2014, Mode of action framework for receptor-mediated toxicity: the peroxisome proliferator-activated receptor alpha (PPARα) as a case study, Crit. Rev. Toxicol., 44, 1, 10.3109/10408444.2013.835784 Corton, 2018, The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions, Arch. Toxicol., 92, 83, 10.1007/s00204-017-2094-7 Deguchi, 2009, Mode of action analysis for the synthetic pyrethroid metofluthrin-induced rat liver tumors: evidence for hepatic CYP2B induction and hepatocyte proliferation, Toxicol. Sci., 108, 69, 10.1093/toxsci/kfp006 ECHA Committee for Risk Assessment, 2011 Elcombe, 2014, Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: a case study with phenobarbital as a model constitutive androstane receptor (CAR) activator, Crit. Rev. Toxicol., 44, 64, 10.3109/10408444.2013.835786 Forbes, 2017, Creation and preliminary characterization of pregnane X receptor and constitutive androstane receptor knockout rats, Drug Metab. Dispos., 45, 1068, 10.1124/dmd.117.075788 Gold, 2001, Compendium of chemical carcinogens by target organ: results of chronic bioassays in rats, mice, hamsters, dogs, and monkeys, Toxicol. Pathol., 29, 639, 10.1080/019262301753385979 Haines, 2018, Comparison of the hepatic and thyroid gland effects of sodium phenobarbital in wild type and constitutive androstane receptor (CAR) knockout rats and pregnenolone-16α-carbonitrile in wild type and pregnane X receptor (PXR) knockout rats, Toxicology, 400-401, 20, 10.1016/j.tox.2018.03.002 Haines, 2018, Comparison of the effects of sodium phenobarbital in wild type and humanized constitutive androstane receptor (CAR)/pregnane X receptor (PXR) mice and in cultured mouse, rat and human hepatocytes, Toxicology, 396-397, 22, 10.1016/j.tox.2018.02.001 Hirose, 2009, Comparison of the effects of the synthetic pyrethroid metofluthrin and phenobarbital on CYP2B form induction and replicative DNA synthesis in cultured rat and human hepatocytes, Toxicology, 258, 64, 10.1016/j.tox.2009.01.007 Huff, 1991, Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents, Environ. Health Perspect., 93, 247, 10.1289/ehp.9193247 Kawamoto, 1999, Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene, Mol. Cell. Biol., 19, 6318, 10.1128/MCB.19.9.6318 Lake, 2009, Species differences in the hepatic effects of inducers of CYP2B and CYP4A subfamily forms: relationship to rodent liver tumour formation, Xenobiotica, 39, 582, 10.1080/00498250903098184 Lake, 2018, Human relevance of rodent liver tumour formation by constitutive androstane receptor (CAR) activators, Toxicol. Res., 7, 697, 10.1039/C8TX00008E La Vecchia, 2014, A review of epidemiological data on epilepsy, phenobarbital, and risk of liver cancer, Eur. J. Cancer Prev., 23, 1, 10.1097/CEJ.0b013e32836014c8 Lazarow, 1976, A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug, Proc. Natl. Acad. Sci. U. S. A., 73, 2043, 10.1073/pnas.73.6.2043 LeBaron, 2014, Human relevance framework for rodent liver tumors induced by the insecticide sulfoxaflor, Crit. Rev. Toxicol., 44, 15, 10.3109/10408444.2014.910751 Lowry, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6 Lubet, 1990, Induction of hepatic cytochrome P-450 mediated alkoxyresorufin O-dealkylase activities in different species by prototype P-450 inducers, Chem.-Biol. Interact., 75, 325, 10.1016/0009-2797(90)90075-X Meek, 2014, New developments in the evolution and application of the WHO/IPCS framework on mode of action/species concordance analysis, J. Appl. Toxicol., 34, 1, 10.1002/jat.2949 Mitchell, 1984, Factors influencing peroxisome proliferation in cultured rat hepatocytes, Arch. Toxicol., 55, 239, 10.1007/BF00341018 Mutoh, 2009, Dephosphorylation of threonine 38 is required for nuclear translocation and activation of human xenobiotic receptor CAR (NR1I3), J. Biol. Chem., 284, 34785, 10.1074/jbc.M109.048108 OECD, 1997 Okuda, 2017, Evaluation of the human relevance of the constitutive androstane receptor-mediated mode of action for rat hepatocellular tumor formation by the synthetic pyrethroid momfluorothrin, J. Toxicol. Sci., 42, 773, 10.2131/jts.42.773 Okuda, 2017, Mode of action analysis for rat hepatocellular tumors produced by the synthetic pyrethroid momfluorothrin: evidence for activation of the constitutive androstane receptor and mitogenicity in rat hepatocytes, Toxicol. Sci., 158, 412, 10.1093/toxsci/kfx102 Omiecinski, 2011, Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities, Toxicol. Sci., 120, S49, 10.1093/toxsci/kfq338 Osimitz, 2009, Mode-of-action analysis for induction of rat liver tumors by pyrethrins: relevance to human cancer risk, Crit. Rev. Toxicol., 39, 501, 10.1080/10408440902914014 Parzefall, 1991, Testing for induction of DNA synthesis in human hepatocyte primary cultures by rat liver tumor promoters, Cancer Res., 51, 1143 Peffer, 2018, Minimum data sets to establish a CAR-mediated mode of action for rodent liver tumors, Regul. Toxicol. Pharmacol., 96, 106, 10.1016/j.yrtph.2018.04.001 Plant, 1998, The coordinate regulation of DNA synthesis and suppression of apoptosis is differentially regulated by the liver growth agents, phenobarbital and methylclofenapate, Carcinogenesis, 19, 1521, 10.1093/carcin/19.9.1521 Renwick, 2001, Evaluation of 7-benzyloxy-4-trifluoromethylcoumarin, some other 7-hydroxy-4-trifluoromethylcoumarin derivatives and 7-benzyloxyquinoline as fluorescent substrates for rat hepatic cytochrome P450 enzymes, Xenobiotica, 31, 861, 10.1080/00498250110074063 Soldatow, 2016, Development of an in vitro high content imaging assay for quantitative assessment of CAR-dependent mouse, rat, and human primary hepatocyte proliferation, Toxicol. In Vitro, 36, 224, 10.1016/j.tiv.2016.08.006 Thoolen, 2012, Comparative histomorphological review of rat and human hepatocellular proliferative lesions, J. Toxicol. Pathol., 25, 189, 10.1293/tox.25.189 Tinwell, 2014, Liver tumor formation in female rat induced by fluopyram is mediated by CAR/PXR nuclear receptor activation, Regul. Toxicol. Pharmacol., 70, 648, 10.1016/j.yrtph.2014.09.011 Wei, 2000, The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism, Nature, 407, 920, 10.1038/35038112 Yamada, 2018, Case examples of an evaluation of the human relevance of the pyrethroids/pyrethrins-induced liver tumours in rodents based on the mode of action, Toxicol. Res., 7, 681, 10.1039/C7TX00288B Yamada, 2015, Lack of effect of metofluthrin and sodium phenobarbital on replicative DNA synthesis and Ki-67 mRNA expression in cultured human hepatocytes, Toxicol. Res., 4, 901, 10.1039/C4TX00217B Yamada, 2014, Human hepatocytes support the hypertrophic but not the hyperplastic responses to the murine nongenotoxic hepatocarcinogen sodium phenobarbital in an in vivo study using a chimeric mouse with humanized liver, Toxicol. Sci., 142, 137, 10.1093/toxsci/kfu173 Yamamoto, 2004, The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice, Cancer Res., 64, 7197, 10.1158/0008-5472.CAN-04-1459